Champignon Brands Announces Contract Research Partner For Ketamine, Psilocybin IP Portfolio
Champignon Brands (CSE: SHRM) announced this morning that it is advancing its drug discovery program with the selection of Dalriada as the firms contract research organization. Dalriada will advance Champignon’s new chemical entity IP portfolio in the areas of ketamine and psilocybin molecular scaffolds. The partnership with Dalriada is expected to bring a robust pipeline […]
Sunniva Sells Okanagan Falls Property For $9.0 Million
Sunniva Inc (CSE: SNN) has finally given it up. This morning, the company announced that after close to a year in delays, they have cancelled the agreement with CannaPharmaRx to sell the Okanagan Falls property for $20 million. Instead, the company will be selling the property to an independent real estate investment fund. Under the […]
Monterrey Minerals Announces 2020 Exploration Program At Alicia Project
Monterey Minerals (CSE: MREY) revealed its 2020 exploration plans at its flagship Alicia high-grade gold project in Alicia Municipality, Philippines. The focus for the program will be to prove continuity between identified veins and to better understand the larger system at depth, while beginning groundwork for a JORC or NI 43-101 resource. Highlights from the […]
Great Bear Strikes Again! Gold Explorer Hits 30.51 g/t Au Over 12.40m
This morning Great Bear Resources (TSXV: GBR) announced results from their $21 million exploration program at their Dixie Project in the Red Lake District. The highlight was hole 133 which received results including: 30.51 g/t Au over 12.40 metres 103.56 g/t Au over 1.10 metres 15.45 g/t Au over 25.15 metres Great Bear has completed 111 of approximately 300 […]
PowerBand Sees Additional US$2.7 Million Investment From D&P Holdings
PowerBand Solutions (TSXV: PBX) has secured an additional US$2.7 million from Texas-based D&P Holdings Inc as part of the previously announced US$10 million investment by the firm. The additional investment comes as PowerBand prepares to commence vehicle lease originations this month in the US. The funding injection from D&P will be put towards PowerBand’s leasing […]
Medipharm Secures $37.8 Million In Convertible Notes
Medipharm Labs (TSX: LABS) this morning announced that it has secured aggregate gross proceeds of $37.8 million via a private placement conducted with an institutional investor. The placement has taken the form of two separate offerings, one of which is a convertible note, while the other is a subscription receipt. The first portion of the […]
Sundial Manages To Restructure Outstanding Debt
Sundial Growers (NASDAQ: SNDL) has finally managed to complete the restructuring of its outstanding debt so as to be able to continue its operations. The company this morning announced a total of four transactions that are taking place to enable it to restructure its debt. First and foremost, its outstanding senior secured credit facility has […]
CMHC Tightens Mortgage Borrowing Criteria
Recently, Canada’s housing agency has decided it will be implementing a series of measures aimed at high-risk mortgage borrowers, in order to supposedly stabilize housing markets due to the predicted housing price decline. However, the move is being met with criticism, as it could further hinder the economy’s recovery. Canada Mortgage & Housing Corp (CMHC), […]
Practice of Earnings Guidance Should End, According to Expedia Chairman Barry Diller
The coronavirus pandemic has turned the entire economy upside down, causing businesses and companies to unprecedented hardships. As a result, many companies decided to withdrawal issuing earning guidance given the current economic uncertainty and volatility. However, one billionaire businessman thinks that long-term earnings forecasts should be scrapped altogether – and permanently. Speaking on CNBC’s Squawk […]
Antibe Therapeutics Posts Positive Study Results, Insiders Unload Positions
Antibe Therapeutics (TSXV: ATE) this past week published results on its latest drug development for the treatment of osteoarthritis pain. The study, classified as “Phase 2B” was for the purpose of measuring dose ranging against efficacy. As per the company, the results demonstrated a “high level of statistical significance” when compared to that of the […]